Alyeska Investment Group, L.P. Deciphera Pharmaceuticals, Inc. Transaction History

Alyeska Investment Group, L.P.

$18 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $290,904 - $450,840	20,400 New	20,400 $315,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $818,249 - $1.2 Million	-25,000 Reduced 14.89%	142,932 $5.23 Million
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $2.07 Million - $2.91 Million	51,339 Added 44.03%	167,932 $7.53 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $1.83 Million - $2.34 Million	-35,376 Reduced 23.28%	116,593 $6.65 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $3.09 Million - $4.1 Million	70,523 Added 86.59%	151,969 $7.8 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $2.09 Million - $3.67 Million	56,446 Added 225.78%	81,446 $4.86 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $4.64 Million - $9.58 Million	-137,993 Reduced 84.66%	25,000 $1.03 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $474,849 - $924,707	23,802 Added 17.1%	162,993 $5.53 Million
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $1.81 Million - $2.25 Million	85,910 Added 161.24%	139,191 $0
Q1 2019 May 15, 2019	SELL	$20.65 - $29.55 $820,197 - $1.17 Million	-39,719 Reduced 42.71%	53,281 $0
Q4 2018 Feb 14, 2019	SELL	$19.08 - $36.14 $927,421 - $1.76 Million	-48,607 Reduced 34.33%	93,000 $1.95 Million
Q2 2018 Aug 14, 2018	BUY	$20.06 - $44.95 $1.33 Million - $2.98 Million	66,278 Added 87.98%	141,607 $5.57 Million
Q1 2018 May 15, 2018	SELL	$20.04 - $29.71 $502,723 - $745,305	-25,086 Reduced 24.98%	75,329 $1.51 Million
Q4 2017 Feb 14, 2018	SELL	$16.54 - $24.2 $53,506 - $78,287	-3,235 Reduced 3.12%	100,415 $2.28 Million
Q3 2017 Nov 14, 2017	BUY	$17.65 - $18.99 $1.83 Million - $1.97 Million	103,650	103,650 $1.97 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Account